The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
To examine the change in sleep patterns and mood symptoms in response to eszopiclone
(Lunesta) using a double-blind placebo-controlled cross-over study design in perimenopausal
and postmenopausal women who experience insomnia, mild depression and/or anxiety.